CY1110182T1 - Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων - Google Patents

Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων

Info

Publication number
CY1110182T1
CY1110182T1 CY20101100628T CY101100628T CY1110182T1 CY 1110182 T1 CY1110182 T1 CY 1110182T1 CY 20101100628 T CY20101100628 T CY 20101100628T CY 101100628 T CY101100628 T CY 101100628T CY 1110182 T1 CY1110182 T1 CY 1110182T1
Authority
CY
Cyprus
Prior art keywords
ideenonon
treatment
muscle dystrophy
treating
muscular dystrophy
Prior art date
Application number
CY20101100628T
Other languages
English (en)
Inventor
Thomas Meier
Gunnar Buyse
Original Assignee
Santhera Pharmaceuticals (Schweiz) Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36572153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110182(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Santhera Pharmaceuticals (Schweiz) Ag filed Critical Santhera Pharmaceuticals (Schweiz) Ag
Publication of CY1110182T1 publication Critical patent/CY1110182T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Χρήση της ιδεβενόνης για την παρασκευή ενός φαρμάκου για την θεραπεία μιας μυϊκής δυστροφίας συγκεκριμένα για τη θεραπεία και/ή πρόληψη της αδυναμίας και/ή της απώλειας ιστού σκελετικών μυών και/ή της μυοκαρδιοπάθειας που σχετίζεται με κάποια μυϊκή δυστροφία.
CY20101100628T 2005-03-21 2010-07-06 Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων CY1110182T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05006137 2005-03-21
EP06723554A EP1861080B1 (en) 2005-03-21 2006-03-20 Idebenone for the treatment of muscular dystrophies

Publications (1)

Publication Number Publication Date
CY1110182T1 true CY1110182T1 (el) 2015-01-14

Family

ID=36572153

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100628T CY1110182T1 (el) 2005-03-21 2010-07-06 Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων

Country Status (17)

Country Link
US (1) US7977388B2 (el)
EP (1) EP1861080B1 (el)
JP (1) JP4896123B2 (el)
AT (1) ATE468849T1 (el)
AU (1) AU2006226623B2 (el)
CA (1) CA2602290C (el)
CY (1) CY1110182T1 (el)
DE (1) DE602006014514D1 (el)
DK (1) DK1861080T3 (el)
ES (1) ES2345353T3 (el)
MX (1) MX2007011571A (el)
NZ (1) NZ561235A (el)
PL (1) PL1861080T3 (el)
PT (1) PT1861080E (el)
SI (1) SI1861080T1 (el)
WO (1) WO2006100017A1 (el)
ZA (1) ZA200707833B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5537152B2 (ja) 2006-08-01 2014-07-02 フリクサス ファーマシューティカルズ， インコーポレイテッド 慢性進行性心不全のための処置
EP1891946A1 (en) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
ES2436781T3 (es) * 2007-12-17 2014-01-07 The Regents Of The University Of Michigan Composiciones y procedimientos de tratamiento y prevención de deficiencias de músculo esquelético
DK2108366T3 (da) * 2008-04-09 2012-01-30 Santhera Pharmaceuticals Ch Idebenon til behandling af respiratorisk sygdom ved muskeldystrofi
EP2246048A1 (en) * 2009-04-30 2010-11-03 Santhera Pharmaceuticals (Schweiz) AG Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
RS55173B1 (sr) 2010-08-16 2017-01-31 Santhera Pharmaceuticals (Schweiz) Ag Uređaj i sistem za proizvodnju aerosola sa poboljšanim protokom vazduha
CN103086861B (zh) * 2012-11-12 2015-09-16 刘炜 羟癸基苯醌衍生物及其用途
WO2021127003A1 (en) * 2019-12-16 2021-06-24 Children's Medical Center Corporation Treating heart disease in muscular dystrophy patients
EP4351545A1 (en) 2021-06-07 2024-04-17 Katholieke Universiteit Leuven Idebenone in the treatment of drug resistant epilepsy
CN113827585B (zh) * 2021-10-27 2023-04-11 山东大学齐鲁医院 艾地苯在治疗肢带型肌营养不良2g型中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8562998A (en) 1997-08-12 1999-03-01 Takeda Chemical Industries Ltd. Idebenone-containing preparation for percutaneous administration
JPH11116470A (ja) 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
US20030013772A1 (en) * 2000-02-23 2003-01-16 Murphy Michael A. Composition, synthesis and therapeutic applications of polyamines
US6133322A (en) * 1998-10-29 2000-10-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
US20040081961A1 (en) * 2001-05-04 2004-04-29 Delegeane Angelo M Proteases
EP1618881A1 (en) * 2004-07-20 2006-01-25 Santhera Pharmaceuticals (Schweiz) GmbH Use of non-glucocorticoid steroids for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
CA2602290C (en) 2012-01-17
MX2007011571A (es) 2007-12-06
US7977388B2 (en) 2011-07-12
ATE468849T1 (de) 2010-06-15
DE602006014514D1 (el) 2010-07-08
EP1861080A1 (en) 2007-12-05
DK1861080T3 (da) 2010-09-06
ES2345353T3 (es) 2010-09-21
NZ561235A (en) 2010-12-24
AU2006226623B2 (en) 2010-04-22
US20090012050A1 (en) 2009-01-08
EP1861080B1 (en) 2010-05-26
PL1861080T3 (pl) 2010-10-29
JP4896123B2 (ja) 2012-03-14
AU2006226623A1 (en) 2006-09-28
CA2602290A1 (en) 2006-09-28
PT1861080E (pt) 2010-06-17
SI1861080T1 (sl) 2010-08-31
ZA200707833B (en) 2008-06-25
JP2008533182A (ja) 2008-08-21
WO2006100017A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
EP1912650B8 (en) Use of flibanserin in the treatment of obesity
EP1890627A4 (en) SUBDERMIC CRYOGENIC REMODELING OF MUSCLES, NERFS, CONNECTIVE TISSUES, AND / OR ADIPOSE TISSUE (GREASE)
CR8012A (es) Clavo endomedular destinado al tratamiento de fracturas de femur proximal
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
EP1991218A4 (en) USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
IL196965A (en) Analogues of (r, r) or (s, r) phenoterol, their pharmaceutical composition containing them and their use for the treatment of heart failure
HK1137352A1 (en) Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent
BRPI0911203A2 (pt) peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo.
DE602006000349D1 (de) Medizinisches Instrument mit medizinischer Behandlungselektrode
RS51069B (sr) Upotreba oksikodona za tretiranje visceralnog bola
EP1978983A4 (en) EXTRACT OF DIOSCOREA SP. AND ITS MEDICAL USES
EP1900813A4 (en) NESFATIN, A NEW PHYSIOLOGICAL SUBSTANCE, SUBSTANCE IN CONNECTION WITH THIS AND THE USE OF THE SUBSTANCES
UA88655C2 (ru) S-миртазапин для лечения прилива крови
ZA200703441B (en) Coadministration of tigecycline and digoxin
WO2009027703A3 (en) Identifying organ damage
EP2716285A3 (en) New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss
BRPI0719997A2 (pt) Uso de epotilonas no tratamento de osteoporose e doenças relacionadas
EP1767210A4 (en) MEDICAL USE OF PAEONIFLORIN
RS52038B (en) USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS
WO2007012066A3 (en) TRUNCATED OXIDIZED THYMOSIN β4 AND DERIVATIVES THEREOF
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
AR051035A1 (es) Uso de epotilonas en el tratamiento de metastasis en hueso